Variant position: 289 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 310 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LAHEILAGFLSLIPAWAFYS GAFQRLLLTHYVAYLKLNTKV
Mouse LAHEIIAIILNRIPSRIFYS STAQRFLLTRYSDYLKRNISN
Rat LAHEILAIILNLIPSRIFYS STTQRFLLKQFSDYLKSNISN
Zebrafish ITHTLLGRIVQSIPTWVLQS ETFQH----HFQEYVK-NRDR
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 310 17-beta-hydroxysteroid dehydrogenase type 3
NIEHS SNPs program;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS ILE-31 AND SER-289;
Deleterious missense mutations and silent polymorphism in the human 17beta-hydroxysteroid dehydrogenase 3 gene (HSD17B3).
Moghrabi N.; Hughes I.A.; Dunaif A.; Andersson S.;
J. Clin. Endocrinol. Metab. 83:2855-2860(1998)
Cited for: INVOLVEMENT IN MPH; VARIANTS MPH THR-56 AND SER-130; VARIANT SER-289;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.